A groundbreaking study, supported by the Knight Initiative for Brain Resilience at Stanford’s Wu Tsai Neurosciences Institute, has revealed that…
Read More

A groundbreaking study, supported by the Knight Initiative for Brain Resilience at Stanford’s Wu Tsai Neurosciences Institute, has revealed that…
Read More
In a recent episode of "This Week in Virology" (TWiV), Dr. Daniel Griffin provided his weekly clinical update, delving into…
Read More
The pharmaceutical landscape of the 2020s has been defined by the meteoric rise of GLP-1 receptor agonists. Drugs such as…
Read More
Researchers from the Department of Medicine at the School of Clinical Medicine, LKS Faculty of Medicine, University of Hong Kong…
Read More
The human brain, a complex architecture of approximately 86 billion neurons, undergoes a series of inevitable physiological shifts as it…
Read More
A landmark study published in Science by researchers at The Rockefeller University (NY, USA) has unveiled the most comprehensive atlas…
Read More
The rise of glucagon-like peptide-1 (GLP-1) receptor agonists has fundamentally altered the landscape of metabolic medicine in the United States.…
Read More
The aging process exerts a profound and often debilitating toll on the hippocampus, the specialized region of the brain fundamentally…
Read More
Growing older is an inevitable biological process, one that is increasingly understood to be a significant risk factor for a…
Read More
As the prevalence of glucagon-like peptide-1 (GLP-1) receptor agonists continues to reshape the landscape of metabolic health in the United…
Read More